BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16322846)

  • 1. [Ocular toxicity caused by tamoxifen: case report].
    Inada ET; Watanabe KP; Tanaka SG; Sakakisbara LA
    Arq Bras Oftalmol; 2005; 68(4):554-6. PubMed ID: 16322846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ocular toxicity caused by chloroquine: case report].
    Inada ET; Watanabe KP; Tanaka SG; Sakakisbara LA
    Arq Bras Oftalmol; 2005; 68(3):407-9. PubMed ID: 16059580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen retinopathy: does it really exist?
    Lazzaroni F; Scorolli L; Pizzoleo CF; Savini G; De Nigris A; Giosa F; Meduri RA
    Graefes Arch Clin Exp Ophthalmol; 1998 Sep; 236(9):669-73. PubMed ID: 9782427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis.
    Shinkai A; Saito W; Hashimoto Y; Ishida S
    BMC Ophthalmol; 2019 Dec; 19(1):267. PubMed ID: 31888549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystalline maculopathy: a rare complication of tamoxifen therapy.
    Srikantia N; Mukesh S; Krishnaswamy M
    J Cancer Res Ther; 2010; 6(3):313-5. PubMed ID: 21119261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of tamoxifen keratopathy.
    Zinchuk O; Watanabe M; Hayashi N; Fukushima A; Ueno H
    Arch Ophthalmol; 2006 Jul; 124(7):1046-8. PubMed ID: 16832031
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen-associated eye disease. A review.
    Nayfield SG; Gorin MB
    J Clin Oncol; 1996 Mar; 14(3):1018-26. PubMed ID: 8622006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen side effects, age-related macular degeneration (AMD) or cancer associated retinopathy (CAR)?
    Sadowski B; Kriegbaum C; Apfelstedt-Sylla E
    Eur J Ophthalmol; 2001; 11(3):309-12. PubMed ID: 11681514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The optical imaging and clinical features of tamoxifen associated macular hole: A case report and review of the literatures.
    Hu Y; Liu N; Chen Y
    Photodiagnosis Photodyn Ther; 2017 Mar; 17():35-38. PubMed ID: 27746263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory Tamoxifen-Induced Keratopathy Despite Drug Withdrawal.
    Andreanos K; Oikonomakis K; Droutsas K; Petrelli M; Kymionis G
    Cornea; 2017 Mar; 36(3):377-378. PubMed ID: 27918356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The eyes have it! Tamoxifen maculopathy revisited: a case report.
    Nair AG; Das D; Goyal A; Gandhi RA
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):640-2. PubMed ID: 22731242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atrophic tamoxifen maculopathy].
    Hui-Bon-Hoa AA; Defoort-Dhellemmes S; Tran TH
    J Fr Ophtalmol; 2011 Jan; 34(1):35.e1-5. PubMed ID: 21112124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unusual symptoms for tamoxifen-associated maculopathy].
    Hager T; Hoffmann S; Seitz B
    Ophthalmologe; 2010 Aug; 107(8):750-2. PubMed ID: 20393723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Branch retinal vein occlusion associated with tamoxifen use.
    Onder Hİ; Kilic AC; Kose SA; Karatas A; Kaya E; Kaya M; Tunc M
    Semin Ophthalmol; 2013 Mar; 28(2):88-90. PubMed ID: 23448563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled study of the ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinoma.
    Longstaff S; Sigurdsson H; O'Keeffe M; Ogston S; Preece P
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1805-8. PubMed ID: 2632262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular toxicity in low-dose tamoxifen: a prospective study.
    Noureddin BN; Seoud M; Bashshur Z; Salem Z; Shamseddin A; Khalil A
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():729-33. PubMed ID: 10707134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we discontinue tamoxifen in a patient with vision-threatening ocular toxicity related to low-dose tamoxifen therapy?
    Tsai DC; Chen SJ; Chiou SH; Lee AF; Lee FL; Hsu WM
    Eye (Lond); 2003 Mar; 17(2):276-8. PubMed ID: 12640432
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.
    Wolf-Schnurrbusch UEK; Leung I; Sallo FB; Clemons TE; Chew EY; Bird AC; Peto T;
    Ophthalmic Res; 2018; 60(1):38-42. PubMed ID: 28903123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare case: Branch retinal vein occlusion associated with the use of tamoxifen.
    Demirci NS; Erdem GU; Uçgun Nİ; Bozkaya Y; Ozdemir NY; Dogan M; Zengin N
    J Cancer Res Ther; 2019; 15(3):722-724. PubMed ID: 31169251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen-induced total alopecia.
    Puglisi F; Aprile G; Sobrero A
    Ann Intern Med; 2001 Jun; 134(12):1154-5. PubMed ID: 11412069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.